throbber
ESTTA Tracking number:
`
`ESTTA1363502
`
`Filing date:
`
`06/06/2024
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Ex Parte Appeal -
`Serial No.
`
`97172345
`
`Appellant
`
`Imperative Care, Inc.
`
`Applied for mark
`
`Z
`
`Correspondence
`address
`
`STEVEN J. NATAUPSKY
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 MAIN STREET, 14TH FLOOR
`IRVINE, CA 92614
`UNITED STATES
`Primary email: efiling@knobbe.com
`949-760-0404
`
`Submission
`
`Attachments
`
`Filer's name
`
`Filer's email
`
`Signature
`
`Date
`
`Reply brief
`
`Reply Brief.pdf(266536 bytes )
`Exhibits-.pdf(3926156 bytes )
`
`Zoe Vikstrom
`
`efiling@knobbe.com
`
`/Zoe Vikstrom/
`
`06/06/2024
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`Applicant :
`
`Serial No.
`
`Filed
`
`Mark
`
`
`:
`
`:
`
`:
`
`Imperative Care, Inc.
`
`
`
`97/172345
`
`December 14, 2021
`
`Z
`
`APPLICANT’S REPLY BRIEF
`
`Commissioner for Trademarks
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
`Dear Sir or Madam:
`
`
`
`Applicant submits that this Reply Brief is timely filed as Applicant submitted a Motion to
`
`Extend Its Reply Brief Deadline (“Motion to Extend”) by 30 days on May 7, 2024. A true and
`
`correct copy of the Motion to Extend as filed, along with the confirmation receipt, is attached as
`
`Exhibit A.
`
`I.
`
`The Examining Attorney Incorrectly States that Applicant Did Not Provide
`
`Evidence that Applicant’s Goods are Limited to Brain Surgery
`
`
`
`The Examining Attorney states in the Appeal Brief that Applicant did not provide evidence
`
`that Applicant’s Goods are limited to use during “brain surgery,” and that “Applicant did not cite
`
`to any evidence in the record to support its assertion that vascular catheters cannot serve
`
`neurovascular, cardiovascular, and/or endovascular applications.” See Examining Attorney’s
`
`Appeal Brief, p. 9. This is simply incorrect. See Applicant’s Appeal Brief, pp. 9-10. Moreover,
`
`the term “neurovascular” must be analyzed in the context of Applicant’s entire identification of
`
`goods. Here, Applicant’s applied-for goods are “Medical catheters for use in the neurovascular
`
`
`
`-1-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`system; Access catheters for the introduction of medical devices in the neurovascular system;
`
`Aspiration catheters for use in the neurovascular system; Medical pumps for use in the
`
`neurovascular system, namely, vacuum pumps and aspiration pumps; Medical filters for use in the
`
`neurovascular system, namely, filters for capturing debris and clots in the bloodstream; All of the
`
`foregoing for use by medical healthcare professionals in the neurovascular field” in Class 10
`
`(emphasis added). See Applicant’s Appeal Brief, p. 1. As shown in Applicant’s recitation of goods,
`
`the term “neurovascular” is used to modify the term “system,” and a “neurovascular system” is a
`
`structural unit of the brain. See Molecular Neurobiology Volume 57 (July 28, 2020) (defining
`
`“neurovascular system” as “a functional and structural unit of the brain”). See Exhibit B.
`
`Moreover, the Collins Dictionary defines “neuro” as “of a nerve, nerves, or the nervous system.”
`
`See Exhibit C. The Board may take judicial notice of dictionary definitions that (1) are available
`
`in a printed format, (2) are the electronic equivalent of a print reference work, or (3) have regular
`
`fixed editions. See TBMP §1208.04; TMEP §710.01(c); see also Fed. R. Evid. 201; 37 C.F.R.
`
`§2.122(a). Thus, Applicant has provided evidence that its goods, neurovascular catheters, are
`
`limited to use with the brain.
`
`By contrast, the goods identified in the Cited Marks Z2, Z-TRAK, and Z-TRAK PLUS do
`
`not have neurovascular system applications and none of the recitations of goods for these
`
`registrations include the wording “neurovascular”. Instead, the goods identified in the Cited Mark
`
`Z2 are limited to coronary guiding catheters. Coronary is defined by the Merriam Webster
`
`Dictionary as “of or relating to the heart.” See Exhibit D. In addition, the catheters identified in
`
`the Cited Marks Z-TRAK and Z-TRAK PLUS are limited to use with “endovascular grafts.”
`
`“Graft” is defined by Taber’s Medical Dictionary as “Tissue transplanted or implanted in a part of
`
`the body to repair a defect” and is defined by Merriam Webster Dictionary as “to implant (living
`
`
`
`-2-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`tissue) surgically.” See Exhibit E. The Board may take judicial notice of these dictionary
`
`definitions. See TBMP §1208.04; TMEP §710.01(c); see also Fed. R. Evid. 201; 37 C.F.R.
`
`§2.122(a).
`
`Surgeons using coronary guiding catheters and catheters for endovascular grafts are using
`
`these sophisticated medical devices to perform different procedures on entirely different parts of
`
`the body than neurosurgeons using neurovascular catheters during procedures involving the
`
`neurovascular system. Given these considerable differences between these medical devices, their
`
`intended uses, and the types of highly skilled and technically trained physicians using such medical
`
`devices, such physicians and medical device purchasing agents are not likely to be confused as to
`
`the source of such medical devices. This is further demonstrated by the co-existence of the Cited
`
`Marks with numerous other Z marks on the register for medical goods. See Applicant’s Brief,
`
`pp.20-24. Moreover, the peaceful co-existence of the cited registration for Z2 (owned by
`
`Medtronic, Inc.) with Z-TRAK and Z-TRAK PLUS (owned by Cook Medical Technologies LLC),
`
`shows that these highly sophisticated and discerning consumers can readily distinguish between
`
`the marks and the respective medical devices, even where these goods can be broadly categorized
`
`as “catheters”.
`
`II.
`
`The Evidence of Record Does Not Demonstrate
`
`that Applicant’s
`
`Neurovascular System Catheters are Related to the Surgical Instruments Identified
`
`in the Cited Mark
`
`Owned by Zimmer, Inc.
`
`The Examining Attorney asserts that Applicant’s neurovascular system catheters are
`
`directly overlapping with the surgical instruments and apparatuses identified in Registration No.
`
`
`
`-3-
`
`

`

`TSP.145T
`97/172345
`Z
`
` Trademark Trial and Appeal Board
`
`2478454 for the Cited Mark
`
`because Applicant’s Goods are used during surgical
`
`procedures in the medical field. See Examining Attorney’s Appeal Brief, p.6. However, the
`
`Principles of Neurological Surgery (Fourth Edition 2018) defines “surgical instruments” as “tools
`
`that allow surgeons to open the soft tissue, remove the bone, dissect and isolate the lesion, and
`
`remove or obliterate the abnormal structures of the treatment.” See Exhibit F. By contrast,
`
`neurovascular catheters are defined by the Merriam Webster Dictionary as “a tubular medical
`
`device[s] for insertion into canals, vessels, passageways, or body cavities usually to permit
`
`injection or withdrawal of fluids or to keep a passage open.” (emphasis added). See Exhibit G.
`
`The Board may take judicial notice of these dictionary definitions. See TBMP §1208.04; TMEP
`
`§710.01(c); see also Fed. R. Evid. 201; 37 C.F.R. §2.122(a).
`
`Catheters cannot and do not function to lacerate and remove tissue, bones, lesions, or other
`
`abnormal structures within the human body, and therefore, do not fall within the definition of
`
`“surgical instruments.” Indeed, the file history of the
`
`registration does not identify
`
`catheters in its line of surgical instruments. See Applicant’s Response to Office Action, Exhibit
`
`B.
`
`Accordingly, the Examining Attorney does not provide proper weight to the very
`
`significant differences between Applicant’s neurovascular system catheters used during brain
`
`procedures by neurosurgeons and Registrant’s general surgical instruments used by general
`
`surgeons to cut tissue or bone. The evidence of record establishes that Applicant’s Goods and
`
`those in the cited registrations are unrelated such that the relevant consumers, who are highly
`
`-4-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`sophisticated and highly trained physicians and/or medical purchasing agents, are unlikely to be
`
`confused.
`
`III. The Examining Attorney’s Internet Evidence Fails to Establish that the Goods
`
`in the Cited Marks and Applicant’s Goods are Related
`
`The Examining Attorney asserts that the evidence of record shows “a wide swath of these
`
`[surgical] instruments are provided by the same brand” and that Applicant’s Goods are
`
`“encompassed by the broad identifications in the cited registrations such as ‘a full line of surgical
`
`instruments and apparatuses.’” See Examining Attorney’s Appeal Brief, p.8. This contention is
`
`flawed for two reasons. First, as established above, Applicant’s Goods are not “surgical
`
`instruments” and do not overlap with the other types of catheters offered under the cited
`
`registrations. Second, the Examining Attorney’s contention is unsupported by case law. Goods
`
`are not deemed related for purposes of a likelihood of confusion analysis simply because they both
`
`appear on a company’s website. Instead, to support a conclusion that the respective marks are
`
`confusingly similar, the goods specified in the application must be related to the goods listed in
`
`the cited marks such that consumers would be confused about the source of origin. See T.M.E.P.
`
`§ 1207.01(a)(i). If the goods are not related or marketed in such a way that they would not be
`
`encountered by the same people in situations that would create the incorrect assumption that they
`
`originate from the same source, then there is no likelihood of confusion, even if the marks are
`
`identical. See id.
`
`Here, the Examining Attorney submitted webpage printouts of the brand MicroVention
`
`(see Final Office Action, p. 25-26), which includes a wide variety of products, including a balloon
`
`catheter and an aspiration pump:
`
`
`
`-5-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`.
`
`The fact that these two goods are offered by the same large medical device company does
`
`not show that they are similar or related in any way. These devices serve completely different
`
`purposes and are fundamentally different from one another, particularly amongst the highly trained
`
`medical professionals who use these medical products. Similarly, Applicant’s neurovascular
`
`catheters are not related to general surgical instruments simply because they each appear on a
`
`single company’s website. Therefore, the Examining Attorney’s examples of “large swaths” of
`
`products being offered under the same marks discounts a fundamental step in the likelihood of
`
`confusion analysis—comparing the similarity of the goods and whether they are marketed in such
`
`a way that they would not be encountered by the same consumers in situations that would create
`
`the false assumption that the products originate from the same source. Because surgical
`
`instruments for cutting tissue or bone are fundamendtally different from neurovascular catheters
`
`used during brain surgery, and highly trained and specialized neurosurgeons are fundamentally
`
`different from other types of surgeons, these goods are not related or marketed to the same
`
`consumers. Indeed, neurosurgeons are one of the most highly specialized medical practitioners in
`
`any medical system, and as such, they do not also perform general surgery. Similarly,
`
`cardiovascular surgeons are also highly trained physicians that cannot and do not perform
`
`
`
`-6-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`neurosurgery. As such, these highly trained physicians would not be using the same types of
`
`instruments to perform these fundamentally different surgical procedures on completely different
`
`parts of the body.
`
`IV.
`
`It Is Unreasonable to Assume, and There is No Evidence Supporting the
`
`Proposition, that Surgeons in the Same School or Hospital Would Discuss Applicant’s
`
`Mark and the Cited Marks and Be Confused as to the Source of Applicant’s Goods
`
`The Examining Attorney states that “in the absence of evidence to the contrary, it is
`
`reasonable to believe that surgeons at the same school or hospital do have a working relationship
`
`and may discuss their work and their tools with one another, and to assume that one surgeon’s “Z”
`
`brand of tools is the same “Z” brand used by their colleagues.” See Examining Attorney’s Appeal
`
`Brief, pp. 10-11. Applicant respectfully disagrees. First, Applicant has provided evidence to the
`
`contrary in its Appeal Brief (see Applicant’s Appeal Brief, pp. 6-10), including that neurosurgeons
`
`using neurovascular system catheters in brain surgery undergo different training and specialties as
`
`compared to surgeons using general surgery instruments, endovascular catheters for endovascular
`
`grafts, and coronary guiding catheters. Second, it is the Examining Attorney’s burden to prove a
`
`likelihood of confusion, and there is simply no evidence that these conversations occur. In
`
`addition, a hypothetical possibility of confusion does not create a likelihood of confusion. The
`
`Federal Circuit has specifically held: “[w]e are not concerned with mere theoretical possibilities
`
`of confusion, deception, or mistake or with de minimus situations but with the practicalities of the
`
`commercial world, with which the trademark laws deal.” Elec. Design & Sales, Inc. v. Elec. Data
`
`Sys. Corp., 954 F.2d 713, 719, 21 U.S.P.Q.2d (BNA) 1388, 1393 (Fed. Cir. 1992) (citing Witco
`
`Chem., 418 F.2d at 1405). Likelihood of confusion “is synonymous with ‘probable’ confusion—
`
`it is not sufficient if confusion is merely ‘possible.’” 4 McCarthy on Trademarks and Unfair
`
`
`
`-7-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`Competition § 23:3 (5th ed.) (quoting Am. Steel Foundries v. Robertson, 269 U.S. 372, 383 (1926));
`
`see also Mtd Prods. Inc. v. Universal Tire Corp., 193 U.S.P.Q. (BNA) ¶ 56 (T.T.A.B. Oct. 18,
`
`1976) (“A possibility of such confusion always exists, but what may be possible may not at all be
`
`probable and, if not probable, it is not likely.”).
`
`Moreover, the mere remote possibility that two surgeons working at the same school or
`
`hospital could discuss their respective medical devices with each other does not demonstrate that
`
`such highly sophisticated consumers would be likely to be confused as to the source of these goods.
`
`Indeed, the standard is not a possibility of confusion, but a likelihood or probability of confusion.
`
`See id. Indeed, the marketplace has already demonstrated that the
`
`registrations and the
`
`Z2, Z-TRAK, and Z-TRAK PLUS registrations can peacefully co-existence. Given the
`
`sophistication and high degree of purchasing care of the relevant consumers, the very different
`
`nature of the goods and the procedures under which they are used, and the differences in the
`
`appearance and/or spelling of the marks, confusion is simply not probable.
`
`As described above, the purpose and the nature of Applicant’s Goods (neurovascular
`
`system catheters used in neurosurgery) and the goods in connection with the Cited Marks (general
`
`surgery instruments, endovascular catheters, and coronary guiding catheters) are completely
`
`distinct and used by exceedingly sophisticated surgeons who are trained in completely different
`
`types of surgical procedures on distinct parts of the body. Therefore, these specialized surgeons
`
`and highly sophisticated medical device purchasing agents are acutely aware of the differences
`
`between these respective goods, and it simply is implausible that the relevant consumers are likely
`
`to be confused as to the source of these medical products after having a brief conversation with a
`
`colleague.
`
`
`
`-8-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`V.
`
`The Examining Attorney Mischaracterizes the Scope of Protection of
`
`Applicant’s Mark
`
`The Examining Attorney mischaracterizes the scope of protection of Applicant’s Mark
`
`when stating Applicant’s Mark is legally identical to the registrations for the mark
`
`. See
`
`Examining Attorney’s Appeal Brief, p. 4. Indeed, the rights associated with a mark presented in
`
`standard characters pertain only to “font style, size, or color” and do not apply to any additional
`
`shapes or design elements. See In re Viterra Inc., 671 F.3d 1358, 1364-65, 101 USPQ2d 1905,
`
`1910 (Fed. Cir. 2012); Citigroup Inc. v. Cap. City Bank Grp., Inc., 637 F.3d 1344, 1353, 98
`
`USPQ2d 1253, 1259 (Fed. Cir. 2011); In re Aquitaine Wine USA, LLC, 126 USPQ2d at 1187 ("We
`
`hold that when we are comparing a standard character mark to a word + design mark for Section
`
`2(d) purposes, we will consider variations of the depictions of the standard character mark only
`
`with regard to ‘font style, size, or color’ of the ‘words, letters, numbers, or any combination
`
`thereof.’"). Given that the
`
`registrations include a circle design, whereas Applicant’s
`
`Mark does not, the marks are not legally identical as Applicant’s plain block letter filing does not
`
`provide any claim to additional shapes or designs. In addition, the
`
`registrations are not
`
`entitled to a broad scope of protection in view of the peaceful co-existence of these marks with
`
`other standalone “Z” marks in Class 10 for medical goods. See Applicant’s Appeal Brief, pp. 20-
`
`24. Thus, consumers will readily perceive even very subtle differences between the marks and/or
`
`the underlying goods, particularly as Applicant’s neurovascular catheters serve very different
`
`purposes from registrant’s general surgical instruments, as discussed above. In view of the
`
`significant differences in the respective goods, the high degree of purchasing care exercised by the
`
`
`
`-9-
`
`

`

`TSP.145T
`97/172345
`Z
`
`
`
` Trademark Trial and Appeal Board
`
`relevant consumers, the narrow scope of protection for these registrations, and the difference
`
`between the appearances of the respective marks, confusion is not likely.
`
`VI. Conclusion
`
`Applicant respectfully requests that the likelihood of confusion refusal be reversed and that
`
`Applicant’s Mark be approved for publication.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`KNOBBE, MARTENS, OLSON, & BEAR LLP
`
`By:
`
`/Zoe Vikstrom/
`
`
`
`
`
`
`
`
`
`Steven J. Nataupsky
`Jonathan Menkes
`Zoe Vikstrom
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`(949) 760-0404
`efiling@knobbe.com
`
`-10-
`
`

`

`
`
`
`
`
`
`
`
`
`
`Exhibit A
`Exhibit A
`
`

`

`    ÿ
ÿ
`#$#$%#%&
` ÿ! "
`'(ÿ)ÿ*('+ÿ ÿ, (ÿ (+ÿ- +. -/ÿ0'1
`20-ÿ)ÿ- +. -/ÿ-' 3ÿ (+ÿ ,, 3ÿ20 -+
`4ÿ678
` 79ÿ:ÿ 8 79
`>?@?ABCD
`;<=
` 997E
`'FG"
H"ÿ1
"Iÿ'
`9 JÿK<8
`N
`L78M
`Q(ÿRÿ(  *,/S
`/(022Iÿ. -(Iÿ030(ÿTÿ2 -Iÿ33,
`AUCUÿ. '(ÿ-Iÿ@C)ÿ300-
`O<88 P<EJ E
`'-Q'(Iÿ1 ÿ>AV@C
`7JJ8 PP
`*('+ÿ 
`,
F
Wÿ"F  ÿ"X YZZ"F
`>C>[?VU[UCUC
`\]L PP <E
`ÿX "ÿ ÿ
"G WÿZ
"X
`7^L EPD[?[ACÿ ,,3'1 (ÿ.0'0(ÿ0-ÿ_('0(ÿ0ÿ'.ÿ0ÿ'3
`-,0(ÿ2-'ÿG!X`?AC>>ÿZW "aÿb
`c 9 8dPÿE7L N"ÿQa
F
`c 9 8dPÿ L7 9e"Ha
FYZZ"FIÿ"X YZZ"F
` fE7\8
`gN"ÿQa
Fg
`h7
`UDgU?gAUAC
` \8Eÿ<ÿÿ^<L ÿ7f ÿi^Pj$$ P7=\P<=f<k$lÿÿÿ78ÿ7E<^ 8
`ÿK 9 Efÿi^Pj$$ P7=\P<=f<k$K 9 Ef:m =nPl
`opqqrstuuvvvwxsrqywzy{u|
`}~€‚ÿ}„ÿ…†‡ˆ
`
`

`

`
`
`
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Applicant :
`
`Serial No.
`
`Filed
`
`Mark
`
`
`:
`
`:
`
`:
`
`
`
`Imperative Care, Inc.
`
`
`
`97/172345
`
`December 14, 2021
`
`Z
`
`APPLICANT’S MOTION FOR EXTENSION OF TIME TO FILE RESPONSE BRIEF
`
`Pursuant to T.B.M.P. §1203.02(d) and 1203.02(c), Applicant respectfully requests a 30-
`
`
`
`day extension of time within which to file its Reply Brief. Applicant submits that good cause
`
`exists for this extension request.
`
`Applicant respectfully requests that the Board grant Applicant a short extension request as
`
`Applicant needs additional time to confer with its counsel. As the short extension request will not
`
`cause any prejudice to the USPTO, Applicant respectfully requests that the extension request be
`
`granted.
`
`
`
`
`
`
`
`
`
`
`
` Respectfully submitted,
`
`
`
`
`
`
`
`Dated: May 7, 2024
`
`
`
`
`
`
`
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`
`
`/Zoe Vikstrom/
`
`By:
`
`Steven J. Nataupsky
`
`Zoe Vikstrom
`
`Attorneys for Applicant
`2040 Main Street, 14th Floor
`
`
`Irvine, CA 92614
`
`(949) 760-0404
`
`
`
`
`
`

`

`
`
`
`
`
`
`
`
`
`
`Exhibit B
`Exhibit B
`
`

`

`Advertisement
`
`nature
`>
`~<& ww
`Life and Biological Sciences
`communications
`a
`a
`Browse our TOP 25 most read articles published in 2023
`Se
`(cid:8212)(cid:8212)
`
`
`
`
`
`
`
`(cid:8212)
`ae
`
`:
`
`Learn more
`
`SPRINGER LINK
`
`Findajournal
`
`Publishwithus
`
`Trackyourresearch
`
`Q Search
`
`Home > Molecular Neurobiology > Article
`
`The Role of Neurovascular System in
`Neurodegenerative Diseases
`
`Published: 28 July 2020
`
`Volume 57, pages 4373-4393, (2020)
`
`Cite this article
`
`Login
`
`D Cart
`
`Molecular Neurobiology
`
`Aims and scope >
`
`Submit manuscript >
`
`Ajmal Ahmad, Vanisha Patel, Jianfeng Xiao & Mohammad Moshahid Khan 4 Access this article
`
`S) 2947 Accesses fy 49 Citations &) 13 Altmetric
`
`S11 Mention
`
`Exploreallmetrics >
`
`Abstract
`
`Loginviaaninstitution >
`
`
`|
`(
`Buy article PDF USD 39.95
`)
`
`
`The neurovascular system (NVS), which consisted of neurons, glia, and vascular cells, isa
`
`Price excludes VAT (USA)
`
`functional and structural unit of the brain. The NVS regulates blood-brain barrier (BBB)
`
`Tax calculation will be finalised during checkout.
`
`permeability and cerebral blood flow (CBF), thereby maintaining the brain(cid:8217)s
`
`Instant access to the full article PDF.
`
`microenvironment for normal functioning, neuronal survival, and information processing.
`;
`-o,
`oo
`,
`Recent studies have highlighted the role of vascular dysfunction in several
`
`So
`Rent this article via DeepDyve (2
`
`neurodegenerative diseases. This is not unexpected since both nervous and vascular
`
`systems are functionally interdependent and show close anatomical apposition, as well as
`
`similar molecular pathways. However, despite extensive research, the precise mechanism
`
`by which neurovascular dysfunction contributes to neurodegeneration remains
`
`incomplete. Therefore, understanding the mechanisms of neurovascular dysfunction in
`
`disease conditions may allow us to develop potent and effective therapies for prevention
`
`and treatment of neurodegenerative diseases. This review article summarizes the current
`.
`.
`.
`.
`.
`.
`research in the context of neurovascular signaling associated with neurodegenerative
`
`.
`i,
`Institutional subscriptions >
`
`Figures
`
`References
`
`Sections
`
`Abstract
`
`References
`
`OO
`Fundin
`ess
`
`diseases, such as Alzheimer(cid:8217)s disease (AD), Parkinson(cid:8217)s disease (PD), amyotrophic lateral
`
`Author information
`
`sclerosis (ALS), and Huntington(cid:8217)s disease (HD). We also discuss the potential implication of
`
`Ethics declarations
`
`neurovascular factor as a novel therapeutic target and prognostic marker in patients with
`
`neurodegenerative conditions.
`
`.
`;
`wo
`Additional information
`_
`Rights and permissions
`
`About this article
`
`
`
`Endothelial
`
`cell
`
`Tight junction
`(Cjaudins, Occludins.
`
`~~
`

`
`a alernAnnentain
`
`Basement
`
`membrane
`
`Advertisement
`
`Document title: The Role of Neurovascular System in Neurodegenerative Diseases | Molecular Neurobiology
`Capture URL: https://link.springer.com/article/10.1007/s12035-020-02023-z
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:12:57 GMT
`
`
`
`Page 1 of 45
`
`

`

`LICULUVdSCUldl LACLUL dd d LIUVE!L LIICLGVCULIC Ld LPOCL GLIIU PLUBPLIUSLIC INId KEL LI PdaLlleLils WILL
`
`neurodegenerative conditions.
`
`Endothelial
`
`Tight junction
`Basement
`(Claudins, Occludins,
`membrane
`p-glycoprotein
`ZO- 1)
`cell
`
`
`
`
`Endfoot
`Process
`
`Astrocyte
`
`Microglia
`
`
`
`Normal CBF with appropriate
`neurovascular coupling
`* No cognitive deficits
`* No dementia
`* Normal motor function
`¢ Low risk of AD/PD
`* Decreased neurotoxins
`* No abnormal protein aggregation
`* Low risk of ALS/HD
`
`CBF Shortfalls with
`neurovascular uncoupling
`* Neurovascular dysfunction
`* Cognitive deficit and Dementia
`* Motor dysfunction
`¢ High risk of AD/PD
`¢ Increased neurotoxins
`¢ Abnormal protein aggregation
`¢ High risk of ALS/HD
`
`
`
`
`
`
`
`@ This is a preview of subscription content, log in via an institution [4 to check access.
`
`Similar content being viewed by others
`So
`
`Srrocth masse cutls
`
`WNeceee
`
`Serooth reacts ons
`
`&
`
`P| oe (cid:8212)_
`§ | Emer
`
`m=
`fy
`Lew
`
`& | Serenay
`BR] Gu
`a
`
`-
`
`(cid:8212)
`
`Arter
`
`he
`
`/ Wevten
`The
`
`/
`
`_(cid:8212)(cid:8212)(cid:8212) eae
`Ses
`
`-
`
`_
`(cid:8212)
`Captary
`
`==.
`
`(cid:8212)
`
`Verse
`
`
`
`bam»
`
`Actn®
`
`=
`
`<=
`
`The role of brainvasculature
`
`in neurodegenerative
`
`disorders
`
`| Amyloid Beta(cid:8212)Mediated
`Neurovascular Toxicity in
`Alzheimer(cid:8217)s Disease
`
`
`
`Vascular Dysfunction and
`Neurodegenerative Disease
`
`
`
`
`
`Article
`
`24September 2018
`
`Chapter
`
`©2024
`
`Chapter
`
`©2020
`
`References
`
`1. Begley DJ, Brightman MW (2003) Structural and functional aspects of the blood-brain
`
`Document title: The Role of Neurovascular System in Neurodegenerative Diseases | Molecular Neurobiology
`Capture URL: https://link.springer.com/article/10.1007/s12035-020-02023-z
`
`
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:12:57 GMT
`
`
`
`
`
`
`Access this article
`
`
`
`C
`
`Buy article PDF USD 39.95
`
`+)
`
`
`
`
`
`Price excludes VAT (USA)
`
`Tax calculation will be finalised during checkout.
`
`Instant access to the full article PDF.
`
`Rent this article via DeepDyve [4
`
`Institutional subscriptions >
`
`
`
`Sections
`
`Figures
`
`References
`
`Abstract
`
`References
`
`Funding
`
`Author information
`
`Ethics declarations
`
`Additional information
`
`Rights and permissions
`
`About this article
`
`Advertisement
`
`Page 2 of 45
`
`

`

`
`
`
`
`
`
`
`
`
`
`Exhibit C
`Exhibit C
`
`

`

`LANGUAGE
`
`TRANSLATOR
`
`GAMES
`
`SCHOOLS
`
`BLOG
`
`More v
`
`= Collins ve.
`
`o
`4 &
`
`x Q
`
`| Morey
`Portuguese
`|
`Spanish
`|
`Italian
`| German |
`French
`
`
`Your team
`deserves
`better
`
`monday.om
`
`Team projects
`
`a fe)
`
`ie
`
`eas
`
`deserves
`better
`
`Team projects
`
`
`
`
`
`Monday.om
`
`Definition of 'neuro-'
`
`You may also like
`vs
`
`English Quiz
`Confusables
`
`neuro-
`
`in American English
`
`((cid:8216)nurow *); (cid:8216)njurow 4); 'nura 4); 'njora @))
`
`of a nerve, nerves, or the nervous system
`
`neuropathy
`
`Pronunciation
`
`>
`
`
`
`C &w) Wordle Helper
`
`)
`
`
`
`oO
`=(cid:8212)o
`
`
`Language Lover's
`Blog
`
`Quick Word Challenge
`
`Question: 1
`(cid:8212) Score:0 /5
`pedal or peddle?
`
`Which version is correct?
`=F
`He attempted to
`
`peddle his paintings
`around small London
`
`e
`
`galleries.
`\
`(cid:8212)
`TTT
`He attempted to
`pedal his paintings
`
`around small London
`galleries.
`
`
`
`J
`
`
`
`Webster's New World College Dictionary, 4th Edition. Copyright © 2010 by Houghton Mifflin
`
`Harcourt. All rights reserved.
`
`Word origin
`
`< Gr neuron, nerve
`
`neuro-
`
`in American English
`
`COMBINING FORM
`
`neurology
`
`Also (esp. before a vowel): neur-
`
`Most material © 2005, 1997, 1991 by Penguin Random House LLC. Modified entries © 2019 by
`
`Penguin Random House LLC and HarperCollins Publishers Ltd
`

`
`A
`
`\EA OC
`

`
`
`
`Document title: NEURO- definition in American English | Collins English Dictionary
`Capture URL: https://www.collinsdictionary.com/us/dictionary/english/neuro
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:14:05 GMT
`
`Page 1 of 3
`
`

`

`LANGUAGE
`
`TRANSLATOR
`
`GAMES
`
`SCHOOLS
`
`BLOG
`
`More v
`
`= Collins ve.
`
`o
`4 &
`
`x Q
`
`French
`
`| German |
`
`Italian
`
`|
`
`Spanish
`
`|
`
`Portuguese
`
`| Morey
`
`Y
`
`Word origin
`
`Definitions
`
`Pronunciation
`
`>
`
`team
`-
`
`eserves
`better
`
`
`
`monday.on
`
`[< Gk neuro-, comb. form of netiron, akin to L nervus]
`
`neuro-
`in British English
`
`or before a vowel heur-
`
`COMBINING FORM
`
`indicating a nerve or the nervous system
`neuroblast
`
`neurology
`
`Collins English Dictionary. Copyright © HarperCollins Publishers
`
`Word origin
`
`from Greek neuron nerve; related to Latin nervus
`
`Browse alphabetically
`
`neuro-
`
`Related terms of
`
`neuro-
`
`neuristor
`neurite
`
`neuritis
`neuro-
`
`neuro-linguistic programming
`
`New collocations
`added to dictionary
`
`Collocations are words that are
`often used together and are
`brilliant at providing natural
`sounding language for your
`speech and writing.
`
`FEBRUARY 13, 2020
`READ MORE
`
`@o0o000000000
`
`e New from Collins e
`
`Quick Word Challenge
`
`Question: 1
`
`- Score: 0 /5
`
`BIRDS
`
`What is this an image of?
`
`a
`
`Jun 04, 2024
`
`Document title: NEURO- definition in American English | Collins English Dictionary
`Capture URL: https://www.collinsdictionary.com/us/dictionary/english/neuro
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:14:05 GMT
`Page 2 of 3
`
`
`
`
`

`

`LANGUAGE
`
`TRANSLATOR
`
`GAMES
`
`SCHOOLS
`
`BLOG
`
`More v
`
`o
`4 &
`
`= Collins ve.
`
`| Morey
`Portuguese
`|
`Spanish
`|
`Italian
`| German |
`French
`
`Definitions
`Pronunciation
`>
`
`x Q
`
`greenwash
`
`Greenwash is an attempt by
`
`businesses to seem
`
`environmentally friendly without
`
`actually doing anything serious
`
`Your
`team
`deserves
`better
`
`Team projects
`
`into a business.
`
`to protect the environment.
`
`SEE PREVIOUS WORDS
`
`SEE FULL DEFINITION
`
`
`
`Grow your
`side hustle
`
`Collins
`
`Elevate your vocabulary
`Sign up to our newsletter to receive our latest news,
`i
`exclusive content and offers.
`
`Sign up now
`
`Collins Dictionaries
`
`About Collins
`
`Useful Links
`
`Browse all official
`
`About Us
`
`Collins dictionaries
`
`Contact Us
`
`FAQs
`
`Advertise with us
`
`B2B Partnerships
`
`Collins COBUILD
`
`Cookies Settings
`
`Collins ELT
`
`Terms & Conditions
`
`Dictionary API
`
`Privacy Policy
`
`HarperCollins Publishers
`
`California Privacy Rights
`
`Word Banks
`
`Do Not Sell My Personal
`Information
`
`Security
`
`© Collins 2024
`
`X
`
`f OH
`
`Document title: NEURO- definition in American English | Collins English Dictionary
`Capture URL: https://www.collinsdictionary.com/us/dictionary/english/neuro
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:14:05 GMT
`
`Page 3 of 3
`
`

`

`
`
`
`
`
`
`
`
`
`
`Exhibit D
`Exhibit D
`
`

`

`Soe Birla
`
`coronary
`
`
`
`Games & Quizzes
`
`WordoftheDay
`
`Grammar
`
`Wordplay
`
`WordFinder
`
`More
`
`
`
`Merriam-
`Webster
`
`
`
`
`
`Dae ay
`
`Definition
`
`COPrONALY 102 adjective
`
`cor-o-nary ( (cid:8216)kOr-a-,ner-64) ) (cid:8216)kar-,
`
`-,ne-ré
`
`noun
`
`
`
`
`
`Example Sentences
`
`Word History
`
`Phrases Containing
`
`1
`
`2
`
`:of, relating to, resembling, or being a crown or coronal
`
` :of, relating to, or being the coronary arteries or veins of the heart
`
`broadly : of or relating to the heart
`
`COronaly
`
`2.2 noun
`
`Noite] (cid:8364) 10 Waa
`
`adatom re] 6
`
`- Show More v
`
`plural coronaries
`
`1
`
`a: CORONARY ARTERY
`
`b
`
`: CORONARY VEIN
`
`Save Word
`
`2
`
`: CORONARY THROMBOSIS
`
`broadly : HEART ATTACK
`
`
`
`
`
` Quordle
`W
`r>o
`
`O
`
`L
`
`O
`
`ne
`
`(e!
`
`D
`
`L
`AW)
`¥)|S
`a |hlC ee
`Can you solve 4 words at
`once?
`
`
`
`Play
`
`
`
`SHEBA® What Cats Want(cid:8482)
`
`a
`
`1o anyt
`
`for that
`
`zie,
`
`they
`
`Sheba
`
`Shop Now
`
`
`
`
`
`
`
`
`
`> Examples of coronary in a Sentence
`
`Noun
`
`| almost had a coronary when | heard the news.
`
`Recent Examples on the Web
`
`Adjective
`
`But for people with a higher likelihood of heart problems, the risk of
`/
`-
`/
`atrial fibrillation is counterbalanced by the potential anti-inflammatory,
`-
`.
`_
`anti-clotting, and triglyceride-lowering benefits of omega-3 fats, which
`
`Merriam:
`
`WORD OF THE DAY
`
`meliorism@®
`
`See Definitions and Examples »
`
`
`Get Word of the Day daily email!
`
`Your email address
`
`
`
`Document title: Coronary Definition &amp; Meaning - Merriam-Webster
`Capture URL: https://www.merriam-webster.com/dictionary/coronary#:~:text=of%202%20adjective-,cor%C2%B7%E2%80%8Bo%C2%B7%E2%80%8Bnary%20%CB…
`
`
`Capture timestamp (UTC): Tue, 04 Jun 2024 17:15:22 GMT
`Page 1 of 7
`
`
`
`

`

`Merriam) oe Burra)
`
`coronary
`
`
`
`Games & Quizzes
`
`WordoftheDay
`
`Grammar
`
`Wordplay(cid:8217)
`
`Word Finder
`
`
`
`Webster
`
`e
`
`oe
`
`Dictionary
`
`
`
`But for peo

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket